8 Participants not using CPAP were enrolled in trial 1 (234 participants), and those using CPAP were enrolled in trial 2 (235 participants)
In July 2024, a study published in JAMA Ophthalmology reported that patients on semaglutide faced a sevenfold higher risk of vision loss compared to non-users
We should think of these drugs the same way. That is not how most patients view the drug
Standard glutathione pills are often broken down into their individual amino acids (cysteine, glycine, and glutamic acid) by enzymes in the stomach and intestines
If treatment is clinically appropriate, your prescription can be sent right after your visit
So when a June 2024 study published in the Journal of the American Medical Association (JAMA) Ophthalmology suggested a possible link between GLP-1 use and vision loss, headlines warning of blindness spread quickly across news outlets and social media